Carbidopa And Levodopa Tablet
Product Images NDC 72865-363

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 72865-363). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xlcare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10-100mg-1000s Count (10 100mg 1000s)

10-100mg-1000s Count (10 100mg 1000s)
Carbidopa and Levodopa Tablets, USP 10 mg/100 mg oral tablets in a bulk package of 1000 tablets. The label shows the NDC 72865-361-10 and states the product is for prescription use only. Manufactured by Ascent Pharmaceuticals, Inc. and labeled for XL Care Pharmaceuticals, Inc. Storage instructions specify 20° to 25°C with light and moisture protection. The label includes a barcode and a note that the package is not child resistant and not for dispensing.*
FDA Label Image

10-100mg-100s Count (10 100mg 100s)

10-100mg-100s Count (10 100mg 100s)
Label for Carbidopa and Levodopa Tablets, USP 10 mg/100 mg, oral tablet formulation by XL Care Pharmaceuticals Inc. The label states the package contains 100 tablets with prescription use only. It includes storage instructions, dosage reference, and manufacturer details for Ascent Pharmaceuticals, Inc. The label also shows the NDC number 72865-361-01 and a barcode.*
FDA Label Image

25-100mg-1000s Count (25 100mg 1000s)

25-100mg-1000s Count (25 100mg 1000s)
Label for Carbidopa and Levodopa Tablets, USP 25 mg/100 mg manufactured for XLCare Pharmaceuticals, Inc. The label indicates a bulk package containing 1000 tablets with no varnish coating. It includes storage instructions and manufacturer details for Ascent Pharmaceuticals, Inc. The product is prescription-only.*
FDA Label Image

25-100mg-100s Count (25 100mg 100s)

25-100mg-100s Count (25 100mg 100s)
Label for Carbidopa and Levodopa Tablets, USP 25 mg/100 mg oral tablets. The package contains 100 tablets, labeled as prescription only, manufactured for XLCare Pharmaceuticals, Inc. The label includes storage instructions and manufacturer details for Ascent Pharmaceuticals, Inc.*
FDA Label Image

25-250mg-1000s Count (25 250mg 1000s)

25-250mg-1000s Count (25 250mg 1000s)
Label for Carbidopa and Levodopa Tablets, USP 25 mg/250 mg by XLCare Pharmaceuticals, Inc. The label indicates 1000 tablets in a bulk package. Storage instructions and manufacturing details are included, noting the product is Rx only and not child resistant.*
FDA Label Image

25-250mg-100s Count (25 250mg 100s)

25-250mg-100s Count (25 250mg 100s)
Label for Carbidopa and Levodopa Tablets, USP, 25 mg/250 mg strength, containing 100 tablets. The label includes dosage form and strength prominently, manufacturer and distributor information, storage instructions, and a barcode. The label maker is XL Care Pharmaceuticals, Inc.*
FDA Label Image

Carbidopa Structure (Carbidopa Structure)

Carbidopa Structure (Carbidopa Structure)
Chemical structure of Carbidopa as part of the Carbidopa and Levodopa drug product. The diagram shows molecular components including hydroxyl groups, a carboxyl group, an amine group, and a water molecule (H2O).*
FDA Label Image

Levodopa Structure (Levodopa Structure)

Levodopa Structure (Levodopa Structure)
Chemical structure diagram of Carbidopa, showing the molecular arrangement with hydroxyl groups, an amino group, and a carboxylic acid group attached to a benzene ring and side chains.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.